Primary |
Myelodysplastic Syndrome |
44.4% |
Cardiac Failure Congestive |
22.2% |
Benign Prostatic Hyperplasia |
11.1% |
Hypertension |
11.1% |
Oedema Peripheral |
11.1% |
|
Adverse Drug Reaction |
14.3% |
Pneumonia |
14.3% |
Procedural Hypotension |
14.3% |
Renal Impairment |
14.3% |
Swelling |
14.3% |
Syncope |
14.3% |
Thermal Burn |
14.3% |
|
Secondary |
Drug Use For Unknown Indication |
53.3% |
Pneumonia |
13.3% |
Oedema |
10.7% |
Catheter Placement |
5.3% |
Urine Output Decreased |
5.3% |
Depression |
2.7% |
Atrial Fibrillation |
1.3% |
Benign Prostatic Hyperplasia |
1.3% |
Cardiac Failure |
1.3% |
Cerebral Infarction |
1.3% |
Hypertension |
1.3% |
Hypokalaemia |
1.3% |
Parkinson's Disease |
1.3% |
|
Paraesthesia |
15.4% |
Renal Failure |
15.4% |
Renal Failure Chronic |
15.4% |
Sepsis |
15.4% |
Medication Error |
7.7% |
Syncope |
7.7% |
Ventricular Tachycardia |
7.7% |
Vomiting |
7.7% |
Weight Increased |
7.7% |
|
Concomitant |
Drug Use For Unknown Indication |
55.4% |
Hypertension |
6.3% |
Prophylaxis Against Transplant Rejection |
5.9% |
Product Used For Unknown Indication |
4.6% |
Pulmonary Hypertension |
4.0% |
Diabetes Mellitus |
2.7% |
Renal Transplant |
2.7% |
Hyperparathyroidism |
2.5% |
Prophylaxis |
2.2% |
Cardiac Failure |
1.9% |
Vitamin Supplementation |
1.9% |
Multiple Myeloma |
1.6% |
Diuretic Therapy |
1.2% |
Pulmonary Arterial Hypertension |
1.1% |
Cardiac Disorder |
1.0% |
Chronic Myeloid Leukaemia |
1.0% |
Connective Tissue Disorder |
1.0% |
Hypoxia |
1.0% |
Oesophageal Ulcer |
1.0% |
Pain |
1.0% |
|
Right Ventricular Failure |
10.5% |
Death |
9.2% |
Vomiting |
7.9% |
Pneumonia |
6.6% |
Eosinophilia |
5.3% |
Flushing |
5.3% |
Joint Swelling |
5.3% |
Nausea |
5.3% |
Oedema Peripheral |
5.3% |
Renal Impairment |
5.3% |
Pain In Extremity |
3.9% |
Pancytopenia |
3.9% |
Rash |
3.9% |
Sepsis |
3.9% |
Type 2 Diabetes Mellitus |
3.9% |
Urinary Tract Infection |
3.9% |
Dry Mouth |
2.6% |
Dysgeusia |
2.6% |
Fatigue |
2.6% |
Gout |
2.6% |
|